ArticleBritish journal of cancer2013

Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery.

J Posthumadeboer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.